Titlebook: Crohn’s Disease; Basic Principles Alessandro Fichera,Mukta K. Krane Book 2015 Springer International Publishing Switzerland 2015 Body Imagi

thrombus

Surgery: Colon, patients can be challenging, since pathognomonic findings of noncaseating granulomas and transmural inflammation can seldom be demonstrated by simple biopsy. Surgery is rarely curative and is primarily used to treat acute or symptomatic disease. While extensive disease often requires proctocolectom

Physiatrist

interpose

,Perineal Reconstruction in Crohn’s Disease,gical therapy [1]. Unfortunately, proctectomy for Crohn’s disease is associated with a high risk for perineal wound complications [2]. The presence of transphincteric and supralevator fistulas can cause a stiff, fibrotic, and inflamed field in which tension free, re-approximation of the native tissu

Valves

Surgery: Surgical Quality,eam of providers. It is important to identify and mitigate risk factors that may increase complications such as malnutrition, infection, and other medical comorbidities. Patients should receive preoperative oral and parenteral antibiotics and perioperative venous thromboembolism prophylaxis. There i

misanthrope

locus-ceruleus

,Recurrent CD: Surgical Prophylaxis—Kono-S Anastomosis,pproximately 25 % experiencing recurrence at the anastomosis within 5 years of bowel resection. Despite recent advances, pharmacotherapy has not significantly improved the natural history of postoperative CD recurrence. Since its first case in 2003, the antimesenteric handsewn functional end-to-end

灰姑娘

,Recurrent Crohn’s Disease: Surgical Treatment,ence is the typical clinical course. Between 50 and 70 % of patients undergoing surgical treatment of their disease will ultimately require further surgical intervention [1–3]. As such, many of the surgical procedures undertaken for the management of Crohn’s disease are performed in patients who hav

evince

Employee

,History of Crohn’s Disease,py, once predominated by therapeutic nihilism between surgical episodes, has evolved with more sophisticated trials and therapies now including narrowly targeted drugs. Herein, we review the early descriptions of Crohn’s disease prior to its initial description, its origins at The Mount Sinai Hospit

Cabinet

,Molecular and Genetic Factors in Crohn’s Disease,ion in the multitude of factors that interact within the individual patient presumably results in the dozens of different phenotypes of CD (stricturing, fistulizing, inflammatory, ileal, colonic, etc.).